Physician profile
Lashea Young
NPI 1578029625
$1,332.84
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $739 · 2022: $594.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $238.84 | 2021-2022 | |
| Abbvie INC. | $155.51 | 2021-2022 | |
| Organon LLC | $155.20 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $104.66 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $94.00 | 2021-2022 | |
| Daiichi Sankyo INC. | $67.63 | 2021-2022 | |
| Amarin Pharma, INC. | $53.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.96 | 2021 | |
| Glaxosmithkline, LLC. | $44.35 | 2021-2022 | |
| Amgen INC. | $39.28 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $33.89 | 2021 | |
| Currax Pharmaceuticals LLC | $32.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $29.51 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.65 | 2022 | |
| Abbott Laboratories | $22.86 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $21.70 | 2022 | |
| Pfizer INC. | $19.98 | 2021 | |
| Bausch Health US, LLC | $19.41 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.09 | 2022 | |
| Irhythm Technologies, INC. | $18.94 | 2022 | |
| Esperion Therapeutics, INC. | $18.07 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.91 | 2022 | |
| Allergan, INC. | $16.24 | 2021 | |
| Lilly USA, LLC | $13.29 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.72 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.19 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lashea Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.